Skip to main content

Advertisement

SpringerLink
Log in

Differential Expression of Adenosine P1 Receptor ADORA1 and ADORA2A Associated with Glioma Development and Tumor-Associated Epilepsy

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Level of adenosine, an endogenous astrocyte-based neuromodulator, is primarily regulated by adenosine P1 receptors. This study assessed expression of adenosine P1 receptors, ADORA1 (adenosine A1 receptor) and ADORA2A (adenosine A2a receptor) and their association with glioma development and epilepsy in glioma patients. Expression of ADORA1/ADORA2A was assessed immunohistochemically in 65 surgically removed glioma tissue and 21 peri-tumor tissues and 8 cases of normal brain tissues obtained from hematoma patients with cerebral trauma. Immunofluorescence, Western blot, and qRT-PCR were also used to verify immunohistochemical data. Adenosine P1 receptor ADORA1 and ADORA2A proteins were localized in the cell membrane and cytoplasm and ADORA1/ADORA2A immunoreactivity was significantly stronger in glioma and peri-tumor tissues that contained infiltrating tumor cells than in normal brain tissues (p < 0.05). The World Health Organization (WHO) grade III gliomas expressed even higher level of ADORA1 and ADORA2A. Western blot and qRT-PCR confirmed immunohistochemical data. Moreover, higher levels of ADORA1 and ADORA2A expression occurred in high-grade gliomas, in which incidence of epilepsy were lower (p < 0.05). In contrast, a lower level of ADORA1/ADORA2A expression was found in peri-tumor tissues with tumor cell presence from patients with epilepsy compared to patients without epilepsy (p < 0.05). The data from the current study indicates that dysregulation in ADORA1/ADORA2A expression was associated with glioma development, whereas low level of ADORA1/ADORA2A expression could increase susceptibility of tumor-associated epilepsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Goodenberger ML, Jenkins RB (2012) Genetics of adult glioma. Cancer Genet 205(12):613–621

    Article  CAS  PubMed  Google Scholar 

  2. Stewart L, Burdett S, Glioma Meta-analysis Trialists Group (GMT) (2002) Chemotherapy for high-grade glioma. Cochrane Database Syst Rev (4):CD003913. doi:10.1002/14651858.CD003913

  3. van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6(5):421–430

    Article  PubMed  Google Scholar 

  4. Thom M, Blumcke I, Aronica E (2012) Long-term epilepsy-associated tumors. Brain Pathol 22(3):350–379

    Article  PubMed  Google Scholar 

  5. de Mendonca A, Sebastiao AM, Ribeiro JA (2000) Adenosine: Does it have a neuroprotective role after all? Brain Res Brain Res Rev 33(2–3):258–274

    Article  PubMed  Google Scholar 

  6. Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U, Williams M (1997) Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci 18(3):79–82

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46(2):143–156

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H (2009) Purinergic signalling in the nervous system: an overview. Trends Neurosci 32(1):19–29

    Article  CAS  PubMed  Google Scholar 

  9. Boison D (2005) Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 11(1):25–36

    Article  CAS  PubMed  Google Scholar 

  10. Hamil NE, Cock HR, Walker MC (2012) Acute down-regulation of adenosine A(1) receptor activity in status epilepticus. Epilepsia 53(1):177–188

    Article  CAS  PubMed  Google Scholar 

  11. Silva IR, Nehlig A, Rosim FE, Vignoli T, Persike DS, Ferrandon A, Sinigaglia-Coimbra R, Fernandes MJ (2011) The A1 receptor agonist R-Pia reduces the imbalance between cerebral glucose metabolism and blood flow during status epilepticus: could this mechanism be involved with neuroprotection? Neurobiol Dis 41(1):169–176

    Article  CAS  PubMed  Google Scholar 

  12. Mohammad-Zadeh M, Mirnajafi-Zadeh J, Fathollahi Y, Javan M, Jahanshahi A, Noorbakhsh SM, Motamedi F (2009) The role of adenosine A(1) receptors in mediating the inhibitory effects of low frequency stimulation of perforant path on kindling acquisition in rats. Neuroscience 158(4):1632–1643

    Article  CAS  PubMed  Google Scholar 

  13. Rosim FE, Persike DS, Nehlig A, Amorim RP, de Oliveira DM, Fernandes MJ (2011) Differential neuroprotection by A(1) receptor activation and A(2A) receptor inhibition following pilocarpine-induced status epilepticus. Epilepsy Behav 22(2):207–213

    Article  PubMed  Google Scholar 

  14. Wagner AK, Miller MA, Scanlon J, Ren D, Kochanek PM, Conley YP (2010) Adenosine A1 receptor gene variants associated with post-traumatic seizures after severe TBI. Epilepsy Res 90(3):259–272

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Cunha RA (2008) Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity. Neurochem Int 52(1–2):65–72

    Article  CAS  PubMed  Google Scholar 

  16. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LJ, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807–1812

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. de Groot M, Iyer A, Zurolo E, Anink J, Heimans JJ, Boison D, Reijneveld JC, Aronica E (2012) Overexpression of ADK in human astrocytic tumors and peritumoral tissue is related to tumor-associated epilepsy. Epilepsia 53(1):58–66

    Article  PubMed  Google Scholar 

  18. Ravizza T, Boer K, Redeker S, Spliet WG, van Rijen PC, Troost D, Vezzani A, Aronica E (2006) The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 24(1):128–143

    Article  CAS  PubMed  Google Scholar 

  19. Detre S, Saclani JG, Dowsett M (1995) A “quickscore” method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 48(9):876–878

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Shamji MF, Fric-Shamji EC, Benoit BG (2009) Brain tumors and epilepsy: pathophysiology of peritumoral changes. Neurosurg Rev 32(3):275–284

    Article  PubMed  Google Scholar 

  21. Boison D, Stewart KA (2009) Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation. Biochem Pharmacol 78(12):1428–1437

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Cumiskey D, Butler MP, Moynagh PN, O’Connor JJ (2007) Evidence for a role for the group I metabotropic glutamate receptor in the inhibitory effect of tumor necrosis factor-alpha on long-term potentiation. Brain Res 1136(1):13–19

    Article  CAS  PubMed  Google Scholar 

  23. Stellwagen D, Beattie EC, Seo JY, Malenka RC (2005) Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 25(12):3219–3228

    Article  CAS  PubMed  Google Scholar 

  24. Chen JF, Sonsalla PK, Pedata F, Melani A, Domenici MR, Popoli P, Geiger J, Lopes LV, de Mendonca A (2007) Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and “fine tuning” modulation. Prog Neurobiol 83(5):310–331

    Article  CAS  PubMed  Google Scholar 

  25. Bauer A, Langen KJ, Bidmon H, Holschbach MH, Weber S, Olsson RA, Coenen HH, Zilles K (2005) 18F-CPFPX PET identifies changes in cerebral A1 adenosine receptor density caused by glioma invasion. J Nucl Med 46(3):450–454

    CAS  PubMed  Google Scholar 

  26. Boison D (2008) The adenosine kinase hypothesis of epileptogenesis. Prog Neurobiol 84(3):249–262

    Article  CAS  PubMed  Google Scholar 

  27. Hwang SL, Lieu AS, Kuo TH, Lin CL, Chang CZ, Huang TY, Howng SL (2001) Preoperative and postoperative seizures in patients with astrocytic tumours: analysis of incidence and influencing factors. J Clin Neurosci 8(5):426–429

    Article  CAS  PubMed  Google Scholar 

  28. Sebastiao AM, de Mendonca A, Moreira T, Ribeiro JA (2001) Activation of synaptic NMDA receptors by action potential-dependent release of transmitter during hypoxia impairs recovery of synaptic transmission on reoxygenation. J Neurosci 21(21):8564–8571

    CAS  PubMed  Google Scholar 

  29. Boison D (2008) Adenosine as a neuromodulator in neurological diseases. Curr Opin Pharmacol 8(1):2–7

    Article  CAS  PubMed  Google Scholar 

  30. Melani A, De Micheli E, Pinna G, Alfieri A, Corte LD, Pedata F (2003) Adenosine extracellular levels in human brain gliomas: an intraoperative microdialysis study. Neurosci Lett 346(1–2):93–96

    Article  CAS  PubMed  Google Scholar 

  31. Hargus NJ, Jennings C, Perez-Reyes E, Bertram EH, Patel MK (2012) Enhanced actions of adenosine in medial entorhinal cortex layer II stellate neurons in temporal lobe epilepsy are mediated via A(1)-receptor activation. Epilepsia 53(1):168–176

    Article  CAS  PubMed  Google Scholar 

  32. Boison D (2012) Adenosine dysfunction in epilepsy. Glia 60(8):1234–1243

    Article  PubMed  Google Scholar 

  33. Yu L, Frith MC, Suzuki Y, Peterfreund RA, Gearan T, Sugano S, Schwarzschild MA, Weng Z, Fink JS, Chen JF (2004) Characterization of genomic organization of the adenosine A2A receptor gene by molecular and bioinformatics analyses. Brain Res 1000(1–2):156–173

    Article  CAS  PubMed  Google Scholar 

  34. Kobayashi S, Millhorn DE (1999) Stimulation of expression for the adenosine A2A receptor gene by hypoxia in PC12 cells. A potential role in cell protection. J Biol Chem 274(29):20358–20365

    Article  CAS  PubMed  Google Scholar 

  35. Arslan G, Kull B, Fredholm BB (2002) Anoxia redistributes adenosine A(2A) receptors in PC12 cells and increases receptor-mediated formation of cAMP. Naunyn Schmiedebergs Arch Pharmacol 365(2):150–157

    Article  CAS  PubMed  Google Scholar 

  36. Trincavelli ML, Costa B, Tuscano D, Lucacchini A, Martini C (2002) Up-regulation of A(2A) adenosine receptors by proinflammatory cytokines in rat PC12 cells. Biochem Pharmacol 64(4):625–631

    Article  CAS  PubMed  Google Scholar 

  37. Trincavelli ML, Melani A, Guidi S, Cuboni S, Cipriani S, Pedata F, Martini C (2008) Regulation of A(2A) adenosine receptor expression and functioning following permanent focal ischemia in rat brain. J Neurochem 104(2):479–490

    CAS  PubMed  Google Scholar 

  38. Fotheringham JA, Mayne MB, Grant JA, Geiger JD (2004) Activation of adenosine receptors inhibits tumor necrosis factor-alpha release by decreasing TNF-alpha mRNA stability and p38 activity. Eur J Pharmacol 497(1):87–95

    Article  CAS  PubMed  Google Scholar 

  39. Melani A, Corti F, Cellai L, Vannucchi MG, Pedata F (2014) Low doses of the selective adenosine A2A receptor agonist CGS21680 are protective in a rat model of transient cerebral ischemia. Brain Res 1551:59–72

    Article  CAS  PubMed  Google Scholar 

  40. De Sarro G, De Sarro A, Di Paola ED, Bertorelli R (1999) Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice. Eur J Pharmacol 371(2–3):137–145

    Article  PubMed  Google Scholar 

  41. Sofroniew MV (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32(12):638–647

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Lama G, Mangiola A, Anile C, Sabatino G, De Bonis P, Lauriola L, Giannitelli C, La Torre G, Jhanwar-Uniyal M, Sica G, Maira G (2007) Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue. Int J Oncol 30(6):1333–1342

    CAS  PubMed  Google Scholar 

  43. Aronica E, Gorter JA, Jansen GH, Leenstra S, Yankaya B, Troost D (2001) Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex. Acta Neuropathol 101(5):449–459

    CAS  PubMed  Google Scholar 

  44. Wick W, Menn O, Meisner C, Steinbach J, Hermisson M, Tatagiba M, Weller M (2005) Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie 28(8–9):391–396

    CAS  PubMed  Google Scholar 

  45. Dehnhardt M, Palm C, Vieten A, Bauer A, Pietrzyk U (2007) Quantifying the A1AR distribution in peritumoural zones around experimental F98 and C6 rat brain tumours. J Neurooncol 85(1):49–63

    Article  CAS  PubMed  Google Scholar 

  46. Vercueil L (2011) Brain tumor epilepsy: a reappraisal and six remaining issues to be debated. Rev Neurol (Paris) 167(10):751–761

    Article  CAS  Google Scholar 

  47. Van Dycke A, Raedt R, Vonck K, Boon P (2011) Local delivery strategies in epilepsy: a focus on adenosine. Seizure 20(5):376–382

    Article  PubMed  Google Scholar 

  48. Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeois JM (2005) Adenosine and brain function. Int Rev Neurobiol 63:191–270

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported in part by grants from the Scientific Research Foundation of State Education Ministry for the Returned Overseas Chinese Scholars (#2013.1792) and the Department of Science and Technology of Hunan Province, China (#2013FJ4367).

Author information

Authors and Affiliations

  1. Departments of Neurosurgery, Xiangya Hospital, The Central South University, Changsha, 410008, China

    Jun Huang

  2. Departments of Neurology, Xiangya Hospital, The Central South University, 87 Xiangya Road, Changsha, 410008, China

    Ming-Na Chen, Juan Du, Hao Liu, Yu-Jiao He, Guo-Liang Li, Shu-Yu Li, Wei-Ping Liu & Xiao-Yan Long

Authors
  1. Jun Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ming-Na Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Juan Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu-Jiao He
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guo-Liang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shu-Yu Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Wei-Ping Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xiao-Yan Long
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiao-Yan Long.

Ethics declarations

Conflict of interest

The authors declared that there is no conflict of interest in this work.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee of Xiangya Hospital of Central South University (Changsha, Hunan, China) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, J., Chen, MN., Du, J. et al. Differential Expression of Adenosine P1 Receptor ADORA1 and ADORA2A Associated with Glioma Development and Tumor-Associated Epilepsy. Neurochem Res 41, 1774–1783 (2016). https://doi.org/10.1007/s11064-016-1893-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-016-1893-1

Keywords

Search

Navigation